Multi-omics analysis of ILF2 reveals its prognostic value and functional roles across pan-cancer
ILF2 may serve as a potential biomarker for cancer diagnosis, prognosis, and therapeutic targeting. In particular, it holds promise as a novel therapeutic target in hepatocellular carcinoma.
Authors
- Anli Yang (ORCID: https://orcid.org/0000-0003-0966-7285)
- Hailin Tang (ORCID: https://orcid.org/0000-0002-3206-782X)
- Zewei Chen (ORCID: https://orcid.org/0000-0001-7758-7581)
- Huan Xiong (ORCID: https://orcid.org/0000-0001-5401-7834)
- Junjie Xu (ORCID: https://orcid.org/0000-0001-6507-6442)
- Xiaoyan Li (ORCID: https://orcid.org/0000-0002-8807-4199)
Institutions
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1007/s12672-025-03609-6
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project